These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
961 related articles for article (PubMed ID: 9472608)
1. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat. Sawaya BE; Khalili K; Amini S J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608 [TBL] [Abstract][Full Text] [Related]
2. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity. Ansari SA; Safak M; Gallia GL; Sawaya BE; Amini S; Khalili K J Gen Virol; 1999 Oct; 80 ( Pt 10)():2629-2638. PubMed ID: 10573156 [TBL] [Abstract][Full Text] [Related]
3. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036 [TBL] [Abstract][Full Text] [Related]
4. Regulation of HIV-1 gene expression by NF-IL6. Tesmer VM; Bina M J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter. Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur alpha in glial cells. Chen NN; Khalili K J Virol; 1995 Sep; 69(9):5843-8. PubMed ID: 7637031 [TBL] [Abstract][Full Text] [Related]
8. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA. Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790 [TBL] [Abstract][Full Text] [Related]
9. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells. Mondal D; Alam J; Prakash O J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367 [TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes. Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512 [TBL] [Abstract][Full Text] [Related]
12. Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene. Imataka H; Sogawa K; Yasumoto K; Kikuchi Y; Sasano K; Kobayashi A; Hayami M; Fujii-Kuriyama Y EMBO J; 1992 Oct; 11(10):3663-71. PubMed ID: 1356762 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1. Raj GV; Safak M; MacDonald GH; Khalili K J Virol; 1996 Sep; 70(9):5944-53. PubMed ID: 8709216 [TBL] [Abstract][Full Text] [Related]
15. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication. Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411 [TBL] [Abstract][Full Text] [Related]
16. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation. Yurochko AD; Huong SM; Huang ES J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210 [TBL] [Abstract][Full Text] [Related]
17. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity. Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994 [TBL] [Abstract][Full Text] [Related]
18. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat. Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Wang W; Dong L; Saville B; Safe S Mol Endocrinol; 1999 Aug; 13(8):1373-87. PubMed ID: 10446910 [TBL] [Abstract][Full Text] [Related]
20. A Y-box protein is a suppressor factor that decreases thyrotropin receptor gene expression. Ohmori M; Shimura H; Shimura Y; Kohn LD Mol Endocrinol; 1996 Jan; 10(1):76-89. PubMed ID: 8838147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]